MDS Pharma Services provides a full range of generic drug development services, which are available individually or collectively to meet your needs. Our staff stands at the forefront of all issues that affect the drug development and approval process for generics.

For your next bioequivalence program, MDS Pharma Services will help get your product to market faster. We offer global clinical capacity, on-time recruitment capabilities, proactive study design and assay development programs—all of which mean faster study start-up for you.

Our extensive expertise in study design and worldwide regulatory knowledge, together with a comprehensive range of services, helps speed your bioequivalence program through any approval process. Our team of generic drug development professionals will assist you in getting your bioequivalence study approved and your product ready for market.

Early Clinical Research

Phase I-IIa

Bioequivalence Studies

PK/PD

Study Design and Protocol Development

Data Management

Statistical Analysis

PK/PD Analysis

Medical Writing and Reporting

Modeling and Simulation

Consultation

Webinars

First-In-Human Studies